Wave Life Sciences' shares jump 183% as early INLIGHT data on weight-loss drug WVE-007 show notable visceral fat cuts and ...

Northwell Health reports that "Ozempic face" describes the facial changes from rapid weight loss using Ozempic, highlighting ...

Overall, the message is clear: while tirzepatide can help people lose weight and improve their health, those benefits may not ...

Obstructive Sleep Apnea Is a Real Problem Obstructive sleep apnea, or OSA, is a common problem. A recent American Medical ...

Researchers have found that a specific body profile—higher muscle mass combined with a lower visceral fat to muscle ratio—tracks with a younger brain age, according to a study being presented next ...

An experimental medication was shown to help boost weight loss by up to 20%, a study found. Eloralintide, a once-weekly injectable manufactured by Eli Lilly in Indianapolis, led to "meaningful, ...

Visceral fat sits deep in the belly wrapped around your organs, and carrying too much of it can push health risks higher than most people realize. A smart, nourishing breakfast can help chip away at ...

Eli Lilly hit $1 trillion in market value on Friday, making it the first drugmaker to enter the exclusive club dominated by tech giants and underscoring its rise as a weight-loss powerhouse. A more ...

Intracranial electroencephalography measured the brain activity of a patient with obesity and loss-of-control eating after taking tirzepatide (Zepbound), showing the medication suppressed brain ...

Nick Blackmer is a librarian, fact-checker, and researcher with more than 20 years of experience in consumer-facing health and wellness content. Eli Lilly decreased the prices of Zepbound and ...

A low-fat vegan diet is associated with a significant reduction in greenhouse gas emissions (GHGE) and cumulative energy demand (CED) compared to the Standard American Diet, according to research by ...

Novo Nordisk on Monday lowered the direct-to-consumer prices of its weight loss drug Wegovy and diabetes treatment Ozempic in a challenge to Eli Lilly’s Zepbound after President Donald Trump announced ...